Page 774 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 774

References     3


                   63. Aldrich TK, Hendler JM, Vizioli LD, et al. Intrinsic positive   pulmonary disease.  Am J Respir Crit Care Med. 1996;153:
                      end-expiratory pressure in ambulatory patients with airways   1958-1964.
                      obstruction. Am Rev Respir Dis. 1993;147:845-849.    81. Orozco-Levi M. Structure and function of the respiratory
                   64. Smith TC, Marini JJ. Impact of PEEP on lung mechanics and   muscles in patients with COPD: impairment or adaptation? Eur
                      work of breathing in severe airflow obstruction. J Appl Physiol.   Respir J Suppl. 2003;46:41s-51s.
                      1988;65:1488-1499.                                   82. Grootendorst DC, Gauw SA, Baan R, et al. Does a single dose
                   65. Polkey  MI, Kyroussis  D, Hamnegard  CH, et  al. Diaphragm   of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce
                      strength in chronic obstructive pulmonary disease. Am J Respir   bronchodilation in patients with chronic obstructive pulmo-
                      Crit Care Med. 1996;154:1310-1317.                     nary disease? Pulm Pharmacol Ther. 2003;16:115-120.
                   66. Whittaker JS, Ryan CF, Buckley PA, et al. The effects of refeed-    83. Wright PE, Marini JJ, Bernard GR. In vitro versus in vivo com-
                      ing on peripheral and respiratory muscle function in malnour-  parison of endotracheal tube airflow resistance. Am Rev Respir
                      ished chronic obstructive pulmonary disease patients. Am Rev   Dis. 1989;140:10-16.
                      Respir Dis. 1990;142:283-288.                        84. Girault C, Breton L, Richard JC, et al. Mechanical effects of
                   67. Decramer  M,  Lacquet  LM,  Fagard  R,  et  al.  Corticosteroids   airway humidification devices in difficult to wean patients.
                        contribute to muscle weakness in chronic airflow obstruction.   Crit Care Med. 2003;31:1306-1311.
                      Am J Respir Crit Care Med. 1994;150:11-16.           85. Fujino Y, Uchiyama A, Mashimo T, et al. Spontaneously breath-
                   68. Pittinger C, Adamson R. Antibiotic blockade of neuromuscular   ing lung model comparison of work of breathing between auto-
                      function. Annu Rev Pharmacol. 1972;12:169-184.         matic tube compensation and pressure support.  Respir Care.
                                                                             2003;48:38-45.
                   69. Miller B, Skupin A, Rubenfire M, et al. Respiratory failure
                      produced by severe procainamide intoxication in a patient     86. Barberis L, Manno E, Guerin C. Effect of end-inspiratory
                      with preexisting peripheral neuropathy caused by amiodarone.   pause duration on plateau pressure in mechanically ventilated
                      Chest. 1988;94:663-665.                                patients. Intensive Care Med. 2003;29:130-134.
                   70. Aubier M, Murciano D, Lecocguic Y, et al. Effect of hypophos-    87. Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major
                      phatemia on diaphragmatic contractility in patients with acute   comorbidities in subjects with COPD and incidence of myocar-
                      respiratory failure. N Engl J Med. 1985;313:420-424.   dial infarction and stroke: a comprehensive analysis using data
                   71. Dhingra S, Solven F, Wilson A, et al. Hypomagnesemia and   from primary care. Thorax. 2010;65:956-962.
                      respiratory muscle power. Am Rev Respir Dis. 1984;129:497-498.    88. Wilkinson TM, Donaldson GC, Hurst JR, et al. Early therapy
                   72. Orozco-Levi M, Lloreta J, Minguella J, et al. Injury of the human   improves outcomes of exacerbations of chronic obstructive
                                                                             pulmonary disease.  Am J Respir Crit Care Med. 2004;169(2):
                      diaphragm associated with exertion and chronic obstructive   1298-1303.
                      pulmonary disease.  Am J Respir Crit Care Med. 2001;164:
                      1734-1739.                                           89. Roberts M, Brown J, Kaul S, et al. Non-invasive ventilation in
                   73. Reid WD, Belcastro AN. Time course of diaphragm injury and   chronic obstructive pulmonary disease: management of acute
                                                                             type 2 respiratory failure.  Royal College of Physicians.  http://
                      calpain activity during resistive loading. Am J Respir Crit Care   www.rcplondon.ac.uk/pubs/contents/85efff68-58d4-4382-
                      Med. 2000;162:1801-1806.                               a48e-1e5f20c6187d.pdf. Accessed November 22, 2010.
                   74. Barreiro E, de la Puente B, Minguella J, et al. Oxidative     90. National Institute for Health and Clinical Excellence.  CG101
                      stress and respiratory muscle dysfunction in severe chronic   Chronic Obstructive Pulmonary Disease: Management of Chronic
                      obstructive pulmonary disease.  Am J Respir Crit Care Med.   Obstructive Pulmonary Disease in Adults in Primary and
                      2005;171:1116-1124.                                    Secondary Care. London: National Institute for Health and
                   75. Vassilakopoulos T, Divangahi M, Rallis G, et al. Differential   Clinical Excellence; 2010.
                      cytokine gene expression in the diaphragm in response to     91. Girault C, Briel A, Benichou J, et al. Interface strategy during
                      strenuous resistive breathing.  Am J Respir Crit Care Med.   noninvasive positive pressure ventilation for hypercapnic acute
                      2004;170(2):154-161.                                   respiratory failure. Crit Care Med. 2009;37:124-131.
                   76. Fiaccadori E, Coffrini E, Ronda N, et al. Hypophosphatemia in     92. Ram FS, Picot J, Lightowler J, et al. Non-invasive positive
                      course of chronic obstructive pulmonary disease. Prevalence,     pressure ventilation for treatment of respiratory failure due
                      mechanisms, and relationships with skeletal muscle phosphorus   to exacerbations of chronic obstructive pulmonary disease.
                      content. Chest. 1990;97:857-868.                       Cochrane Database Syst Rev. 2004:CD004104.
                   77. Openbrier DR, Irwin MM, Rogers RM, et al. Nutritional status     93. Williams JW, Cox CE, Hargett CW, et al. Noninvasive
                      and  lung  function  in  patients  with  emphysema  and  chronic     positive-pressure ventilation (NPPV) for acute respiratory
                      bronchitis. Chest. 1983;83:17-22.                        failure. 2012/08/10 ed, 2012.
                   78. Arora NS, Rochester DF. Respiratory muscle strength and     94. Keenan SP, Sinuff T, Cook DJ, et al. Which patients with acute
                        maximal voluntary ventilation in undernourished patients.   exacerbation of chronic obstructive pulmonary disease benefit
                      Am Rev Respir Dis. 1982;126:5-8.                       from noninvasive positive-pressure ventilation? A systematic
                   79. Hamnegard CH, Bake B, Moxham J, et al. Does undernutri-  review of the literature. Ann Intern Med. 2003;138:861-870.
                      tion contribute to diaphragm weakness in patients with severe     95. Kramer N, Meyer TJ, Meharg J, et al. Randomized,  prospective
                      COPD? Clin Nutr. 2002;21:239-243.                      trial of noninvasive positive pressure ventilation in acute
                   80. Decramer M, de Bock V, Dom R. Functional and histologic     respiratory failure. Am J Respir Crit Care Med. 1995;151:1799-
                      picture of steroid-induced myopathy in chronic obstructive   1806.










          Section04-O-ref.indd   3                                                                                  1/21/2015   11:23:20 AM
   769   770   771   772   773   774   775   776   777   778   779